Commonwealth Equity Services’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RXRX
AIM
MCMU
Commonwealth Equity Services's RXRX Position: Q2 2026 in Review
Commonwealth Equity Services reduced its Recursion Pharmaceuticals (RXRX) stake by 9.1% in Q2 2026, selling an estimated $96.7K and leaving 291,939 shares worth $1.07M. The position accounts for ﹤0.01% of the portfolio, ranked #2670.
Commonwealth Equity Services first reported a position in RXRX in Q2 2023 and has held it in 13 quarters since. 342 funds tracked by Wall St. Rank hold RXRX as of Q2 2026.
- Commonwealth Equity Services held 291,939 shares of Recursion Pharmaceuticals worth $1.07M as of Q2 2026.
- Commonwealth Equity Services sold 29,052 Recursion Pharmaceuticals shares in Q2 2026, an estimated $96.7K.
- Recursion Pharmaceuticals made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #2670 holding.
- Commonwealth Equity Services first reported a position in Recursion Pharmaceuticals in Q2 2023 and has held it in 13 quarters since.
- 342 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q2 2026.
Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.